Contract Pharma | New Approaches in Bispecific Antibody Development

  Рет қаралды 2,062

Samsung Biologics

Samsung Biologics

Күн бұрын

In this webinar in collaboration with Contract Pharma, Jina Kim, our Senior Scientist at our Bio R&D Center, shares insights about new approaches in bispecific antibody development while introducing the new bispecific antibody platform S-DUAL™.
#bispecificantibody #bsAb #samsungbiologics #CDO

Пікірлер
Bispecific Antibody Therapy in Multiple Myeloma
28:40
Bispecific Antibody Therapy in Multiple Myeloma
Dana-Farber Cancer Institute
Рет қаралды 809
Bispecific Antibodies Structural Design, Production and Purification Strategies
44:54
Bispecific Antibodies Structural Design, Production and Purification Strategies
GenScript USA Inc.
Рет қаралды 1,4 М.
Беспредельщики из Талгара: «Хуторские» или кто?
01:01
Беспредельщики из Талгара: «Хуторские» или кто?
JURTTYŃ BALASY
Рет қаралды 696 М.
Osman Kalyoncu Sonu Üzücü Saddest Videos Dream Engine 275 #shorts
00:29
Osman Kalyoncu Sonu Üzücü Saddest Videos Dream Engine 275 #shorts
Osman Kalyoncu
Рет қаралды 14 МЛН
бабл ти гель для душа // Eva mash
01:00
бабл ти гель для душа // Eva mash
EVA mash
Рет қаралды 3,8 МЛН
🕊️Valera🕊️
00:34
🕊️Valera🕊️
DO$HIK
Рет қаралды 16 МЛН
PharmTech | Key Considerations When Selecting a mRNA CDMO Partner
28:43
PharmTech | Key Considerations When Selecting a mRNA CDMO Partner
Samsung Biologics
Рет қаралды 1,4 М.
Navigating challenges during formulation development | Webinar
32:34
Navigating challenges during formulation development | Webinar
Samsung Biologics
Рет қаралды 814
Advancing bispecific discovery programs towards clinical success using GS Discovery® and bYlok®
56:06
Advancing bispecific discovery programs towards clinical success using GS Discovery® and bYlok®
The Antibody Society
Рет қаралды 252
2014 Three Minute Thesis winning presentation by Emily Johnston
3:19
2014 Three Minute Thesis winning presentation by Emily Johnston
University of South Australia
Рет қаралды 5 МЛН
Reducing candidate risk with a robust developability assessment tool
21:43
Reducing candidate risk with a robust developability assessment tool
Samsung Biologics
Рет қаралды 677
Breakthrough Bispecific Antibody R&D Techniques
1:01:47
Breakthrough Bispecific Antibody R&D Techniques
Rapid Novor - Protein Sequencing Experts
Рет қаралды 2,3 М.
Therapeutic (Monoclonal) Antibodies
20:39
Therapeutic (Monoclonal) Antibodies
Dirty Medicine
Рет қаралды 90 М.
Victor Davis Hanson: The Final Case for Donald J. Trump
1:14:20
Victor Davis Hanson: The Final Case for Donald J. Trump
Robinson Erhardt
Рет қаралды 404 М.
Immunology - Antibodies (Function)
14:17
Immunology - Antibodies (Function)
Armando Hasudungan
Рет қаралды 543 М.
Drug discovery and development process
7:22
Drug discovery and development process
Novartis
Рет қаралды 566 М.
Беспредельщики из Талгара: «Хуторские» или кто?
01:01
Беспредельщики из Талгара: «Хуторские» или кто?
JURTTYŃ BALASY
Рет қаралды 696 М.